Liver Embolization Approaches for Tumor Management
Recruiting now
Conditions studied: Hepatocellular Carcinoma, Cholangiocarcinoma, Metastatic Colon Cancer, Metastatic Cancer, Metastatic Gastric Cancer, Primary Liver Cancer, Metastatic Pancreatic Cancer
In brief
The goal of this evaluate short, medium and long term outcome of the different embolization techniques in patients with primary and secondary hepatic tumors. The main aim is to evaluate progression free survival following embolization in this study population or evaluate residual hepatic volume in cases in which these techniques are used to induce liver regeneration. This study is an observational registry - all patients will follow their normal therapeutic and treatment scheme as per clinical practice, without any additional intervention.
Key facts
- Study ID
- NCT05714124
- Run by
- IRCCS San Raffaele
- People needed
- 580
- Starts
- 2021-05-21
- Expected to finish
- 2031-12-31
- Last updated by the study team
- 2024-04-12
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- ≥ 18 yoa
- patients with patients with primary or secondary liver disease not amenable for surgery or ablation
- patients with primary or secondary liver tumors candidates for major surgery prior to induction of hypertrophy
- able and willing to sign informed consent
You may not qualify if…
- pregnant women
- patients with uncorrectable coagulopathy
- diffuse extrahepatic disease
- for lobar TACE and TARE - presence of bilodigestive shunt
- for TARE - >20% hepatopulmonary shunt
Where it is running
- IRCCS Ospedale San Raffaele — Milan, Italy (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.